CETP inhibition: Confusion, conflicting results but promising developments
Prof. Philip Barter, Sydney, with a brief update on where we are now with the development of new CETP inhibitors
President, International Atherosclerosis Society
Centre for Vascular Research, University of New South Wales
Sydney, Australia

CETP inhibition: Close to a better understanding of the promise?
Presentation by prof. Philip Barter, MD, Sydney, Australia held during the PACE 2014 SNAPSHOT session on August 30, 2014 in BarcelonaThe information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: